Aigbirhio, Franklin I.
University of Cambridge
30 papers on CoChatORCID 0000-0001-9453-5257
Most cited papers
- Verified
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement
Dalley, J. W., Fryer, T. D., Brichard, L., Robinson, E. S. J., Theobald, D. E. H., Lääne, K., Peña, Y., Murphy, E. R., Shah, Y., Probst, K., et al. (2007) · Science
Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies
Cited by 1,188
- Verified
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
Hansen, J. Y., Shafiei, G., Markello, R. D., Smart, K., Cox, S. M. L., Nørgaard, M., Beliveau, V., Wu, Y., Gallezot, J.-D., Aumont, É., et al. (2022) · Nature Neuroscience
Functional Brain Connectivity StudiesNeurotransmitter Receptor Influence on Behavior
Cited by 797
- Verified
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory
Clatworthy, P. L., Lewis, S. J. G., Brichard, L., Hong, Y. T., Izquierdo, D., Clark, L., Cools, R., Aigbirhio, F. I., Baron, J.-C., Fryer, T. D., et al. (2009) · The Journal of Neuroscience
Neurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity Disorder
Cited by 229
- Verified
Evaluation of the Sensitivity and Specificity of 11 C-Metomidate Positron Emission Tomography (PET)-CT for Lateralizing Aldosterone Secretion by Conn's Adenomas
Burton, T. J., Mackenzie, I. S., Balan, K., Koo, B., Bird, N., Soloviev, D. V., Azizan, E. A. B., Aigbirhio, F., Gurnell, M., & Brown, M. J. (2012) · The Journal of Clinical Endocrinology & Metabolism
Hormonal Regulation and HypertensionAdrenal and Paraganglionic Tumors
Cited by 226
- Verified
Microglial activation and tau burden predict cognitive decline in Alzheimer’s disease
Malpetti, M., Kievit, R. A., Passamonti, L., Jones, P. S., Tsvetanov, K. A., Rittman, T., Mak, E., Nicastro, N., Bevan-Jones, W. R., Su, L., et al. (2020) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 194
- Verified
Amyloid Imaging With Carbon 11–Labeled Pittsburgh Compound B for Traumatic Brain Injury
Hong, Y. T., Veenith, T., Dewar, D., Outtrim, J. G., Mani, V., Williams, C., Pimlott, S., Hutchinson, P. J. A., Tavares, A., Canales, R., et al. (2014) · JAMA Neurology
Traumatic Brain Injury ResearchAlzheimer's disease research and treatments
Cited by 158
- Verified
Early microglial activation and peripheral inflammation in dementia with Lewy bodies
Surendranathan, A., Su, L., Mak, E., Passamonti, L., Hong, Y. T., Arnold, R., Vázquez Rodríguez, P., Bevan-Jones, W. R., Brain, S. A. E., Fryer, T. D., et al. (2018) · Brain
Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments
Cited by 154
- Verified
In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings
Hall, B., Mak, E., Cervenka, S., Aigbirhio, F. I., Rowe, J. B., & O’Brien, J. T. (2017) · Ageing Research Reviews
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 132
- Verified
Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum
Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Kaalund, S. S., Passamonti, L., Allinson, K., Green, O., Hong, Y. T., Fryer, T. D., Arnold, R., et al. (2020) · Brain
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 124
- Verified
Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: Implications for mitochondria-specific therapies and probes
Porteous, C. M., Logan, A., Evans, C., Ledgerwood, E. C., Menon, D. K., Aigbirhio, F., Smith, R. A. J., & Murphy, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects
Mitochondrial Function and PathologyNeuroprotection in Cerebral Ischemia
Cited by 121
- Verified
[ 11 C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Bevan-Jones, W. R., Williamson, D., Jones, P. S., Arnold, R., Borchert, R. J., Surendranathan, A., et al. (2018) · Neurology
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 115
- Verified
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment
del Campo, N., Fryer, T. D., Hong, Y. T., Smith, R., Brichard, L., Acosta-Cabronero, J., Chamberlain, S. R., Tait, R., Izquierdo, D., Regenthal, R., et al. (2013) · Brain
Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior
Cited by 113
- Verified
Synaptic Loss in Primary Tauopathies Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Holland, N., Jones, P. S., Savulich, G., Wiggins, J. K., Hong, Y. T., Fryer, T. D., Manavaki, R., Sephton, S. M., Boros, I., Malpetti, M., et al. (2020) · Movement Disorders
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 93
- Verified
Neuroinflammation predicts disease progression in progressive supranuclear palsy
Malpetti, M., Passamonti, L., Jones, P. S., Street, D., Rittman, T., Fryer, T. D., Hong, Y. T., Vàsquez Rodriguez, P., Bevan-Jones, W. R., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 85
- Verified
[18F]AV-1451 binding in vivo mirrors the expected distribution of TDP-43 pathology in the semantic variant of primary progressive aphasia
Bevan-Jones, W. R., Cope, T. E., Jones, P. S., Passamonti, L., Hong, Y. T., Fryer, T. D., Arnold, R., Allinson, K. S. J., Coles, J. P., Aigbirhio, F. I., et al. (2018) · Journal of Neurology, Neurosurgery & Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 84
- Verified
Neuroinflammation and Tau Colocalize in vivo in Progressive Supranuclear Palsy
Malpetti, M., Passamonti, L., Rittman, T., Jones, P. S., Vázquez Rodríguez, P., Bevan‐Jones, W. R., Hong, Y. T., Fryer, T. D., Aigbirhio, F. I., O'Brien, J. T., et al. (2020) · Annals of Neurology
Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 83
- Verified
Baseline-dependent effects of cocaine pre-exposure on impulsivity and D2/3 receptor availability in the rat striatum: possible relevance to the attention-deficit hyperactivity syndrome
Caprioli, D., Hong, Y. T., Sawiak, S. J., Ferrari, V., Williamson, D. J., Jupp, B., Adrian Carpenter, T., Aigbirhio, F. I., Everitt, B. J., Robbins, T. W., et al. (2013) · Neuropsychopharmacology
Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies
Cited by 58
- Verified
Orbitofrontal Dopamine Depletion Upregulates Caudate Dopamine and Alters Behavior via Changes in Reinforcement Sensitivity
Clarke, H. F., Cardinal, R. N., Rygula, R., Hong, Y. T., Fryer, T. D., Sawiak, S. J., Ferrari, V., Cockcroft, G., Aigbirhio, F. I., Robbins, T. W., et al. (2014) · The Journal of Neuroscience
Neurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment
Cited by 54
- Verified
Synaptic Loss in Frontotemporal Dementia Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
Malpetti, M., Jones, P. S., Cope, T. E., Holland, N., Naessens, M., Rouse, M. A., Rittman, T., Savulich, G., Whiteside, D. J., Street, D., et al. (2023) · Annals of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 53
- Verified
Synaptic density in carriers of C9orf72 mutations: a [11C]UCB‐J PET study
Malpetti, M., Holland, N., Jones, P. S., Ye, R., Cope, T. E., Fryer, T. D., Hong, Y. T., Savulich, G., Rittman, T., Passamonti, L., et al. (2021) · Annals of Clinical and Translational Neurology
Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research
Cited by 44
- Verified
[18F]AV‐1451 PET in behavioral variant frontotemporal dementia due to MAPT mutation
Bevan Jones, W. R., Cope, T. E., Passamonti, L., Fryer, T. D., Hong, Y. T., Aigbirhio, F., Kril, J. J., Forrest, S. L., Allinson, K., Coles, J. P., et al. (2016) · Annals of Clinical and Translational Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 44
- Verified
In vivo PET imaging of neuroinflammation in familial frontotemporal dementia
Malpetti, M., Rittman, T., Jones, P. S., Cope, T. E., Passamonti, L., Bevan-Jones, W. R., Patterson, K., Fryer, T. D., Hong, Y. T., Aigbirhio, F. I., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 43
- Verified
Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study
Holland, N., Malpetti, M., Rittman, T., Mak, E. E., Passamonti, L., Kaalund, S. S., Hezemans, F. H., Jones, P. S., Savulich, G., Hong, Y. T., et al. (2022) · Brain
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 39
- Verified
Benzodiazepine Binding Site Occupancy by the Novel GABAA Receptor Subtype-Selective Drug 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in Rats, Primates, and Humans
Atack, J. R., Wong, D. F., Fryer, T. D., Ryan, C., Sanabria, S., Zhou, Y., Dannals, R. F., Eng, W.-S., Gibson, R. E., Burns, H. D., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics
Neuroscience and Neuropharmacology ResearchPharmacological Receptor Mechanisms and Effects
Cited by 36
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free